Decreased insulin‐stimulated brown adipose tissue glucose uptake after short‐term exercise training in healthy middle‐aged men by Motiani, Piryanka et al.
Decreased insulin#stimulated
brown adipose tissue glucose
uptake after short#term exercise
training in healthy middle#aged men
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Motiani, P., K. A. Virtanen, K. K. Motiani, J. J. Eskelinen, R.
J. Middelbeek, L. J. Goodyear, A. M. Savolainen, et al. 2017.
“Decreased insulin#stimulated brown adipose tissue glucose uptake
after short#term exercise training in healthy middle#aged men.”
Diabetes, Obesity & Metabolism 19 (10): 1379-1388. doi:10.1111/
dom.12947. http://dx.doi.org/10.1111/dom.12947.
Published Version doi:10.1111/dom.12947
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:34492254
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
OR I G I N A L A R T I C L E
Decreased insulin-stimulated brown adipose tissue glucose
uptake after short-term exercise training in healthy middle-
aged men
Piryanka Motiani MD, PhD1 | Kirsi A. Virtanen MD, PhD1 | Kumail K. Motiani MD, PhD1 |
Joonas J. Eskelinen MD, PhD1 | Roeland J.MiddelbeekMD2,3 | Laurie J. Goodyear PhD2 |
AnnaM. SavolainenMD1 | Jukka Kemppainen PhD1,4 | Jørgen Jensen PhD5 |
Mueez U. Din PhD1 | Virva Saunavaara PhD1,6 | Riitta Parkkola1,7 | Eliisa Löyttyniemi8 |
Juhani Knuuti MD, PhD9 | Pirjo Nuutila MD, PhD1,10 | Kari K. Kalliokoski PhD1 |
Jarna C. Hannukainen PhD1
1Turku PET Centre, University of Turku,
Turku, Finland
2Section on Integrative Physiology and
Metabolism, Joslin Diabetes Center, Harvard
Medical School, Boston, Massachusetts
3Division of Endocrinology, Diabetes and
Metabolism, Beth Israel Deaconess Medical
Center, Boston, Massachusetts
4Department of Clinical Physiology and
Nuclear Medicine, Turku University Hospital,
Turku, Finland
5Department of Physical Performance,
Norwegian School of Sport Sciences, Oslo,
Norway
6Department of Medical Physics, Turku
University Hospital, Turku, Finland
7Department of Radiology, Turku University
Hospital, Turku, Finland
8Department of Biostatistics, University of
Turku, Turku, Finland
9Turku PET Centre, Åbo Akademi University,
Turku, Finland
10Department of Endocrinology, Turku
University Hospital, Turku, Finland
Correspondence
Jarna C. Hannukainen PhD, Turku PET Centre,
University of Turku, Turku PO Box 52, FIN-
20521, Finland.
Email: jarna.hannukainen@tyks.fi
Funding Information
This study was supported by the Academy of
Finland, the University of Turku, Turku
University Hospital, and Åbo Akademi
University. The study was also financially
supported by the European Foundation for the
Aims: To test the hypothesis that high-intensity interval training (HIIT) and moderate-intensity
continuous training (MICT) improve brown adipose tissue (BAT) insulin sensitivity.
Participants and methods: Healthy middle-aged men (n = 18, age 47 years [95% confidence
interval {CI} 49, 43], body mass index 25.3 kg/m2 [95% CI 24.1-26.3], peak oxygen uptake
(VO2peak) 34.8 mL/kg/min [95% CI 32.1, 37.4] ) were recruited and randomized into six HIIT or
MICT sessions within 2 weeks. Insulin-stimulated glucose uptake was measured using 2-[18F]
flouro-2-deoxy-D-glucose positron-emission tomography in BAT, skeletal muscle, and abdomi-
nal and femoral subcutaneous and visceral white adipose tissue (WAT) depots before and after
the training interventions.
Results: Training improved VO2peak (P = .0005), insulin-stimulated glucose uptake into the
quadriceps femoris muscle (P = .0009) and femoral subcutaneous WAT (P = .02) but not into
BAT, with no difference between the training modes. Using pre-intervention BAT glucose
uptake, we next stratified subjects into high BAT (>2.9 μmol/100 g/min; n = 6) or low BAT
(<2.9 μmol/100 g/min; n = 12) groups. Interestingly, training decreased insulin-stimulated BAT
glucose uptake in the high BAT group (4.0 [2.8, 5.5] vs 2.5 [1.7, 3.6]; training*BAT, P = .02),
whereas there was no effect of training in the low BAT group (1.5 [1.2, 1.9] vs 1.6 [1.2,
2.0] μmol/100 g/min). Participants in the high BAT group had lower levels of inflammatory
markers compared with those in the low BAT group.
Conclusions: Participants with functionally active BAT have an improved metabolic profile
compared with those with low BAT activity. Short-term exercise training decreased insulin-
stimulated BAT glucose uptake in participants with active BAT, suggesting that training does
not work as a potent stimulus for BAT activation.
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1 | INTRODUCTION
Brown adipose tissue (BAT) has an exceptional thermogenic potential
attributable to mitochondrial uncoupling protein 1 (UCP-1).1,2 BAT is
suggested to regulate energy balance in humans, and enhance glu-
cose homeostasis and insulin sensitivity, and thus may be a potential
therapeutic target for obesity and insulin resistance.3,4 BAT is acti-
vated by cold exposure, and other stimuli, including insulin.5,6 The
effects of exercise training on BAT activity in humans are incom-
pletely understood.
It is well known that regular exercise improves skeletal muscle
insulin sensitivity and whole-body homeostasis. We have shown that
high-intensity interval training (HIIT) and moderate-intensity continu-
ous training (MICT) improve both whole-body and skeletal muscle
insulin-stimulated glucose uptake.7 Limited studies have investigated
the effects of exercise on BAT glucose uptake in humans, and the
data, thus far, have not been consistent. One study showed higher
BAT glucose uptake in people with cancer who had higher self-
reported physical activity compared with those who were sedentary.8
Another study showed significantly lower cold-induced BAT glucose
uptake in trained athletes compared with sedentary men.9 Both of
these studies, however, were cross-sectional investigations, and
studies directly determining the effects of exercise training on BAT
glucose uptake are lacking. In addition, while there has been consid-
erable investigation into the effects of exercise training on glucose
metabolism in humans, data on the effects of exercise training on
fatty acid metabolism in white adipose tissue (WAT) and BAT have
been much more limited.
The aim of the present study was to determine if exercise train-
ing alters insulin-stimulated glucose uptake in BAT. In addition, we
determined if the intensity and duration of exercise training affected
BAT metabolism. Sedentary middle-aged men (n = 18) completed
2 weeks of HIIT or MICT training. Pre- and post-training insulin-
stimulated glucose uptake and fasting free fatty acid (FFA) uptake
were determined in BAT, WAT depots and skeletal muscle using 2-
[18F]flouro-2-deoxy-D-glucose (FDG) and 14(R,S)-[18F]fluoro-6-thia-
heptadecanoic acid (FTHA) and positron-emission tomography (PET)/
computed tomography (CT). We hypothesized that HIIT exercise
training activates BAT, resulting in enhanced insulin-stimulated glu-
cose uptake, and that MICT exercise training increases BAT activity
to a lesser extent. Furthermore, we investigated whether BAT activity
was related to metabolic profile.
2 | PARTICIPANTS AND METHODS
A total of 28 healthy middle-aged sedentary men (age 40-55 years,
body mass index 18.5-30 kg/m2, peak oxygen uptake [VO2Peak]
40 mL/kg/min) were randomized into two groups: HIIT (n = 14) or
MICT (n = 14). The study was approved by the local ethics commit-
tee of the hospital district of South-Western Finland and was carried
out in compliance with the Declaration of Helsinki. Informed consent
was obtained before any measurements were performed. The
recruitment process, and inclusion and exclusion criteria have been
described previously.10 In 7 participants supraclavicular PET scanning
was not possible because of technical difficulties. During the training
intervention, 2 participants withdrew from the HIIT group; 1 because
of training-induced hip pain, and 1 because of illness. One participant
from the MICT group withdrew for personal reasons (total n = 18;
HIIT, n = 7 and MICT, n = 11; Figure 1A,B). The present study is part
of a larger study titled, “The effects of short-term high intensity
interval training on tissue glucose and fat metabolism in healthy sub-
jects and in patients with type 2 diabetes” (Clinicaltrials.gov
#NCT01344928).
2.1 | Study design
At the initial screening visit, physical examination, ECG, blood sam-
pling, a fasting 2-hour 75-g oral glucose tolerance test, and VO2peak
were performed. On the first study day, MRI and fasting [18F]FTHA-
PET/CT scanning were performed, and on the second day we per-
formed [18F]FDG-PET/CT scanning during a euglycaemic–
hyperinsulinaemic clamp. These studies were repeated after the 2-
week exercise intervention, starting with the [18F]-FTHA-PET study
at ~48 hours, followed by a [18F]FDG-PET study at ~72 hours and an
oral glucose tolerance test, and VO2peak test ~96 hours after the last
training session.
2.2 | PET studies
The PET/CT images were acquired using GE Discovery TM ST Sys-
tem (General Electric Medical Systems, Milwaukee, Wisconsin). The
participants fasted ≥12 hours before the PET studies, and avoided
physical activity and both caffeinated and alcoholic drinks for
48 hours before the PET scans. More detailed information is pro-
vided in Appendix S1.
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2.3 | Euglycaemic–hyperinsulinaemic clamp,
exercise intervention, VO2peak test and indirect
calorimetry
The euglycaemic–hyperinsulinaemic clamp technique was used as
described previously.7 The FDG-PET study was performed when the
participant reached the stable glucose concentrations at the level of
5 mmol/L (within 5% range for at least 15 minutes) after positioning
into the PET scanner. Whole-body insulin-stimulated glucose uptake
rate (M-value) was calculated from the measured glucose values col-
lected at steady-state during the PET scan. Participants were rando-
mized into HIIT and MICT exercise intervention protocols. These
protocols consisted of 6 training sessions over a period of 2 weeks.
Sessions 1 and 2 consisted of 4 × 30 seconds of all-out cycling bouts
with 4 minutes of recovery between the bouts (Monark Ergomedic
828E; Monark, Vansbro, Sweden). Sessions 3 and 4 consisted of
5 bouts and sessions 5 and 6 consisted of 6 bouts. Each bout started
with 5-second acceleration to maximum cadence without any resist-
ance, followed by an immediate increase of the load (7.5% of whole-
body weight in kg) for 30 seconds. A MICT session consisted of
cycling at an intensity of 60% of VO2peak (Tunturi E85; Tunturi Fit-
ness, Almere, The Netherlands). The duration of cycling was 40 min-
utes for sessions 1 and 2, 50 minutes for sessions 3 and 4, and
60 minutes for sessions 5 and 6.10 VO2peak was determined 1 week
Recruitment
Physical examination
OGTT
VO2peak
Randomization (n =28)
HIIT
FDG (n = 7)
FTHA (n = 6)
MICT
FDG (n = 11)
FTHA (n = 9)
Technical problems in
FDG scan (n = 1) and
FTHA tracer production
 (n = 3).
PET scanning
No supraclavicular PET
scans (n = 7).
HIIT
FDG (n = 7)
FTHA (n = 6)
MICT
FDG (n = 10)
FTHA (n = 6)
PET scanning (n =28)
fasting FTHA
clamp FDG
Technical problems in
FTHA tracer production
(n = 2). Drop out during
the intervention (n = 1).
Technical problems in
FTHA tracer production
 (n = 1). Drop out during
the intervention (n = 2).
High BAT
Glucose uptake ≥ 2.9 μmol/100g/min 
FDG (n = 6)
FTHA (n = 5)
High BAT
FDG (n = 5)
FTHA (n = 3)
Low BAT
FDG (n = 12)
FTHA (n = 9)
Technical problems in
scan (n=1) and FTHA tracer
production (n = 2).
Low BAT
Glucose uptake ≤ 2.9 μmol/100g/min 
FDG (n = 12)
FTHA (n = 10)
PET Scanning Problems in FTHA
tracer production
 (n = 1)
Supraclavicular PET scans
FDG (n = 18)
FTHA (n = 15)
Exercise Intervention
Supraclavicular PET scanning (n = 18)
Problems in
FTHA tracer
production
(n = 3).
A
B
FIGURE 1 A, Study design for the sub-
study of the larger HITPET
(NCT01344928) study project including
18 healthy middle-aged men randomized
into two training programmes, HIIT and
MICT. B, Study design showing the
division of subjects into high BAT and low
BAT activity groups. OGTT, oral glucose
tolerance test
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before the exercise intervention started and ~96 hours after the last
exercise session, as described previously.7 The open-system indirect
calorimetry (Deltatrac) was used for the measurement of O2 con-
sumption (VO2) and CO2 production (VCO2) to calculate whole-body
energy expenditure and substrate oxidation rates.11,12
2.4 | BAT mass calculation
The BAT mass was analysed by thresholding the voxels from all the
potential sites of BAT (cervical, supraclavicular and axillary adipose
depots) based on Hounsfield units (HU) in the CT image (-250 and -50
HU). All voxels above 2.9 μmol/100 g/min glucose uptake on paramet-
ric PET images were included. Lastly, the volume of all these voxels
(cm3) was converted into mass using BAT density of 0.92 g/cm3.6,13,14
2.5 | Body composition
The MRI scans were carried out using Philips Gyroscan Intera 1.5T CV
Nova Dual scanner (Philips, Amsterdam, the Netherlands). Abdominal
area axial T1-weighted dual fast field echo images (TE 2.3 and 4.7 ms,
TR 120 ms, slice thickness 10 mm without gap) were obtained.
Abdominal subcutaneous and visceral adipose tissue masses were ana-
lysed using SliceOmatic software v.4.3 (http://www.tomovision.com/
products/sliceomatic.htm). To obtain the tissue mass, the pixel surface
area was multiplied by the slice thickness and the density of adipose
tissue 0.9196 kg/L.15 A bioimpedance monitor (InBody 720; Mega
Electronics, Kuopio, Finland) was used to measure body fat percentage.
2.6 | Other measurements
Serum adipokine concentration of nerve growth factor (NGF), inter-
leukin (IL)-6, IL-8, leptin, hepatocyte growth factor (HGF), MCP-1,
and tumour necrosis factor (TNF)-α were analysed using the Adipo-
kine Magnetic Bead Panel 2 (Cat#HADK2MAG-61K; Millipore, Bille-
rica, Massachusetts) on the Luminex-Multiplex analyser (Millipore).
Plasma catecholamines were analysed using a Chromsystems reagent
kit for HPLC analysis (Chromsystems Instruments and Chemicals
GmbH, Munich, Germany) with the Agilent ChemStation chromatog-
raphy program. Plasma total and HDL cholesterol, triglycerides and
glucose were measured from the venous blood samples with an auto-
matized enzymatic assay and insulin using automatized electro-
chemiluminescence immunoassay (Cobas 8000; Roche Diagnostics
GmbH, Mannheim, Germany). LDL cholesterol concentration was cal-
culated using the Friedewald formula.
2.7 | Statistical methods
Descriptive statistics are given as model-based means and 95% confi-
dence intervals (CIs). Normal distribution of the variables was
assessed using the Shapiro–Wilk test, and logarithmic transformation
was carried out for non-normally distributed values (glucose uptake
data, muscle and abdominal visceral adipose tissue FFA uptake, BAT
mass, insulin levels, HDL, IL-6, TNFα, whole-body resting energy
expenditure and catecholamines). Statistical analyses were performed
with hierarchical linear mixed models compound symmetry covari-
ance structure, including 1 within-factor (training; before and after
intervention in the whole group) interaction term (training*group; the
HIIT and MICT groups behaved differently for the change in variable,
with significant differences between the training modes) and (trai-
ning*BAT; the high BAT and low BAT groups behaved differently for
the change in variable, with significant difference between them).
Missing data points were accounted for by restricted maximum likeli-
hood estimation within the linear mixed models. Correlation analyses
were performed between the variables on a whole-group level
(n = 18) using Pearson’s correlation. All values are reported as model-
based mean (SAS least squares means) values from all of the variables
measured before and after training. P values < .05 were taken to indi-
cate statistical significance. The analyses were performed using SAS
System, version 9.3 for Windows (SAS Institute Inc., Cary, North
Carolina).
3 | RESULTS
3.1 | Effects of HIIT and MICT
There were no differences in anthropometrics and glucose and lipid
profiles between HIIT and MICT groups before the intervention
(Table S1A,B, Appendix S1). After training, aerobic capacity increased
by 6% (training P = .0005), and this tended to be higher after HIIT
(9.2%) compared with MICT (3.5%) training (training*group P = .06).
HIIT training lowered LDL cholesterol (training P = .0003; trai-
ning*group P = .01), and tended to lower total cholesterol more than
MICT training (training P = .002; training*group P = .06). Both train-
ing modes reduced whole-body fat percentage by 4% (training
P = .0005) and visceral fat by 8% (training P = .009).
Training improved insulin-stimulated glucose uptake in the quad-
riceps femoris muscle (training P = .0009) and in femoral WAT, but
training effect was not significantly different between the groups
(training P = .02; Figure S1A,B, Appendix S1). Training did not change
the insulin-stimulated glucose uptake rate in BAT, abdominal subcuta-
neous WAT, or in visceral adipose tissue (Figure S1B, Appendix S1).
Exercise training or training mode did not alter FFA uptake in muscle
or BAT (Figure S1C,D, Appendix S1). FFA uptake tended to decrease
in visceral adipose tissue (training P = .07; training*group P = .11)
and in abdominal subcutaneous WAT, with a trend towards greater
decrease after MICT than HIIT (training P = .08; training*group
P = .06; Figure S1D, Appendix S1).
At baseline, BAT glucose uptake correlated inversely with body
mass index (r = -0.55, P = .02), body weight (r = -0.61, P = .01), and
waist circumference (r = -0.52, P = .03), and positively with HDL cho-
lesterol (r = 0.62, P = .01). BAT glucose uptake also correlated with
whole-body insulin sensitivity (M-value; r = 0.64, P = .004), quadriceps
muscle glucose uptake (r = 0.47, P = .04), and visceral fat glucose
uptake (r = -0.55, P = .02). A positive correlation was found between
BAT FFA uptake and muscle FFA uptake (r = 0.73, P = .002).
3.2 | Participants with low and high BAT activity
Brown adipose tissue activity is highly variable between indivi-
duals and we have previously proposed that glucose uptake
>2.9 μmol/100 g/min represents functionally active BAT during
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euglycaemic—hyperinsulinaemic clamp.5,6 All participants were,
therefore, re-stratified into high BAT activity (n = 6) and low BAT
activity (n = 12) groups, based on the baseline insulin-stimulated
BAT glucose uptake threshold of 2.9 μmol/100 g/min (Figure 2A,
B).6 Compared with participants with low BAT activity, those with
high BAT activity had lower body adiposity and leptin concentra-
tion, greater whole-body insulin sensitivity, and higher HDL cho-
lesterol levels at baseline, suggesting a healthier metabolic
phenotype (Table 1). Participants with high BAT activity also
showed lower IL-6 levels, but higher circulating MCP-1 levels.
During insulin stimulation, oxidation of carbohydrates was signifi-
cantly higher in the high BAT than in the low BAT activity groups
(Table 2), which is consistent with better M-values. Despite the
higher BAT glucose uptake, no difference was observed in BAT
FFA uptake (Figure 2D), BAT mass, BAT radiodensity (Table 1), or
quadriceps muscle glucose uptake (Figure 3A) between groups at
baseline. By contrast, visceral adipose tissue glucose uptake was
significantly higher (Figure 3B), and quadriceps muscle FFA uptake
tended to be higher in the high BAT than the low BAT activity
group (P = .06, Figure 3C).
3.3 | Exercise training changes substrate
metabolism in participants with high BAT and those
with low BAT
Two weeks of training decreased insulin-stimulated BAT glucose uptake
in participants with high BAT activity, whereas there was no change in
participants with low BAT activity (training*BAT P = .02; Figure 2B,C).
By contrast, training decreased BAT FFA uptake in the low BAT activity
group, but not in the high BAT activity group (training*BAT P = .01;
Figure 2D,E). There were also no changes in BAT mass or radiodensity
(Table 1) before and after training. There was no association between
the changes in BAT glucose uptake and changes in VO2peak, or between
the changes in BAT glucose uptake and M-value.
Exercise training resulted in similar increases in quadriceps mus-
cle glucose uptake in participants with both high and low BAT activity
FIGURE 2 A, Division of subjects into high BAT (circles) and low BAT activity groups (triangles) with a threshold of 2.9 μmol/100 g/min at
baseline. B, BAT insulin-stimulated glucose uptake (GU) before (white bars) and after the exercise intervention (grey bars). C, Insulin-stimulated
BAT glucose uptake in each individual in the high BAT group before and after the exercise intervention. D, Fasting FFA uptake in high BAT and
low BAT activity groups before and after the exercise intervention. E, Fasting FFA uptake in each individual in the low BAT activity group before
and after the exercise intervention. ##P < .0001, #P = .03 difference between the groups at baseline, ††P = .01, †P = .02 indicates whether high
BAT and low BAT activity groups behaved differently for the change in variable, with significant difference between them (training*BAT)
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(training P = .0009, training *BAT, P = .25, Figure 3A). By contrast,
exercise-induced increases in glucose uptake in femoral WAT tended
to be higher in the high BAT compared with the low BAT activity
group (training P = .02; training*BAT P = .07; Figure 3B). Training
had no effect on muscle FFA uptake in either group (Figure 3C).
Interestingly, training affected IL-6 concentrations differently in the
high BAT and low BAT activity groups, with the high BAT activity
group having an increase and the low BAT activity group having a
decrease in IL-6 (training*BAT P = .04; Table 1). Epinephrine
concentrations increased in both groups after training (training
P = .01, training*BAT P = .53; Table 2).
4 | DISCUSSION
We investigated the effects of short-term exercise training (HIIT and
MICT) on BAT metabolism in sedentary men using FTHA and FDG
PET/CT-scanning. Training increased aerobic capacity and muscle
TABLE 1 Characteristics of high BAT and low BAT activity groups before (Pre) and after exercise training (Post)
High BAT activity (n = 6) Low BAT activity (n = 12) P
Pre Post Pre Post Training Training*BAT
Anthropometrics
Body mass index, kg/m2 23.6 (22, 25)# 23.7(22, 26)# 26.9 (26, 28) 26.8 (26, 28) .93 .75
Fat percentage 18.7 (15, 23)# 17.6 (14, 22) 24.1 (21, 26) 23.7 (21, 26) .04 .37
Waist, cm 87.1 (81, 93)# 86.3 (80, 93)# 98.7 (94, 103) 98.1 (94, 102) .08 .68
VO2peak , mL/kg/min 36.1 (32, 41) 39.1 (35, 44) 33.4 (31, 36) 34.9 (32, 38) .0005 .16
Systolic blood pressure, mm Hg 120 (113, 127) 122 (116, 129)# 127 (122, 133) 131 (127, 135) .13 .61
Diastolic blood pressure, mm Hg 77 (71, 83) 76 (69, 81) 77 (73, 81) 78 (74, 82) .80 .53
Subcutaneous fat mass, kg 3.3 (1.9, 4.6)(#) 3.2 (1.9, 4.5) 4.8 (3.9, 5.7) 4.7 (3.8, 5.6) .15 .85
Visceral fat mass, kg a1.2 (0.7, 2.1)# 1.1 (0.6, 1.1) 3.0 (2.0, 4.3) 2.8 (1.9, 4.1) .009 .30
Glucose profile
M value 48.9 (36, 62)# 49.3 (36, 62) 31.1 (22, 40) 36.8 (28, 46) .13 .18
Glucosefasting, mmol/L 5.3 (5.1, 5.6) 5.8 (5.4, 6.2) 5.5 (5.3, 5.7) 5.7 (5.5, 5.9) .05 .34
Glucoseclamp, mmol/L 5.1 (4.5, 5.7) 5.3 (4.8, 5.8) 5.5 (5.3, 5.8) 5.5 (5.2, 5.7) .47 .35
Insulinfasting, mmol/L
a3.6 (2.5, 5.4)# 3.9 (2.7, 5.8) 5.7 (4.4, 7.4) 5.7 (4.4, 7.5) .54 .62
Insulinclamp, mmol/L 79.5 (64, 95) 81.7(66, 98) 72.3 (62, 83) 74.3 (64, 85) .59 .99
HbA1c, % 5.3 (5.0, 5.6) 5.1 (4.8, 5.4) 5.7 (5.5, 5.9) 5.4 (5.2, 5.6) .003 .70
Lipid profile
FFAfasting 0.82 (0.5, 1.1) 0.91 (0.6, 1.2) 0.65 (0.4, 0.9) 0.61 (0.4, 0.8) .80 .47
FFAclamp 0.46 (0.3, 0.6) 0.51 (0.4, 0.7) 0.41 (0.3, 0.5) 0.37 (0.3, 0.5) .93 .38
Cholesterol, mmol/L 4.85 (4.0, 5.7) 4.24 (3.4, 5.1) 5.09 (4.5, 5.7) 4.61 (4.0, 5.2) .002 .66
LDL cholesterol, mmol/L 2.90 (2.2, 3.6) 2.46 (1.7, 3.2) 3.40 (2.9, 3.9) 3.03 (2.5, 3.5) .004 .77
HDL cholesterol, mmol/L a1.57 (1.4,1.8)## 1.50 (1.3, 1.7)# 1.17 (1.1, 1.3) 1.12 (1.0, 1.2) .27 .99
Triglycerides, mmol/L 0.80 (0.5, 1.1) 0.59 (0.3, 0.9)# 1.10 (0.9, 1.3) 1.00 (0.8, 1.2) .08 .51
Others
Epinephrine a0.14 (0.09, 0.23) 0.17 (0.11, 0.27) 0.14 (0.10, 0.19) 0.25 (0.18, 0.34) .02 .19
Norepinephrine a1.67 (1.2, 2.2) 2.09 (1.6, 2.8) 1.95 (1.6, 2.4) 2.17 (1.8, 2.6) .13 .57
NGF, pmol/L a0.02 (0.01, 0.06) 0.01 (0.01, 0.05) 0.04 (0.02, 0.07) 0.05 (0.03, 0.09) .95 .37
IL-6, pmol/L a0.01 (0.002, 0.04)# 0.01 (0.02, 0.06) 0.06 (0.02, 0.14) 0.02 (0.01, 0.04) .27 .04
IL-8, pmol/L 0.44 (0.2, 0.6) 0.40 (0.2, 0.6) 0.58 (0.5, 0.7) 0.55 (0.4, 0.7) .48 .87
Leptin, pmol/L 87 (58, 232)# 95 (61, 252) 276 (189, 363) 235 (150, 320) .59 .43
HGF, pmol/L 4.2 (1.5, 6.8) 3.8 (0.9, 6.6) 5.3 (3.8, 6.9) 4.3 (2.7, 5.8) .17 .55
MCP-1, pmol/L 22.0 (16, 28)# 23.1 (17, 30) 15.5 (12, 19) 16.6 (13, 20) .20 .99
TNF-α, pmol/L a0.16 (0.1, 0.3) 0.15 (0.1, 0.3) 0.29 (0.2, 0.4) 0.25 (0.2, 0.3) .27 .53
BAT mass (g) a80.1 (43, 148) 81.5 (42, 157) 64.9 (43, 98) 61.8 (41, 94) .95 .89
BAT radiodensity (CT HU) −87.5 (−93, −82) −88.4 (−94, −83) −91.6 (−95, −88) −91.0 (−95, −87) .93 .58
Abbreviation: HbA1c, glycated haemoglobin.
Values are means and 95% CIs.
aLog transformation was done to achieve normal distribution.
#P < .05, ##P < .01 and (#)P = .052 significant difference between groups in corresponding time point. P value (training) indicates the mean changes in
before (pre) and post intervention measurements in the whole group, P-value (training*BAT) indicates whether high BAT and low BAT activity groups
behaved differently for the change in variable with significant difference between them.
Statistically significant values P < .05 are marked as bold.
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insulin sensitivity, but, interestingly, decreased BAT insulin-stimulated
glucose uptake in participants who had highly active BAT to start
with. We also showed that participants with high BAT activity had a
better metabolic profile compared with participants with low BAT
activity before training.
To our knowledge, this is the first study in which BAT metabo-
lism has been quantitated before and after a controlled exercise
training intervention. Contrary to our hypothesis, we found that
2 weeks of exercise training decreases insulin-stimulated BAT glu-
cose uptake in participants with high BAT activity before the inter-
vention. Our results are in line with recent cross-sectional data,
showing reduced cold-stimulated BAT glucose uptake in athletes
compared with sedentary subjects.9 Notably, all the participants in
the study by Vosselman et al.9 seemed to have high BAT activity
TABLE 2 Energy expenditure of high BAT and low BAT groups when fasting and during hyperinsulinaemia
High BAT (n = 6) Low BAT (n = 12) P
Pre Post Pre Post Training Training*BAT
Energy oxidation
Adj REEfasting, MJ/d
a6.62 (6.1, 7.2) 6.62 (6.1, 7.2)# 6.81 (6.4, 7.2) 6.86 (6.5, 7.3) .88 .88
Adj REEclamp, MJ/d
a7.09 (6.6, 7.6) 6.99 (6.5, 7.5) 7.19 (6.8, 7.6) 7.15 (6.8, 7.5) .58 .85
Carbohydratefasting, g/min 2.27 (1.6, 3.0) 1.80 (1.1, 2.5) 2.18 (1.7, 2.7) 2.32 (1.8, 2.9) .58 .32
Carbohydrateclamp, g/min 3.66 (2.9, 4.4)# 3.08 (2.3, 3.8) 2.86 (2.3, 3.4) 2.91 (2.3, 3.4) .34 .26
Fatfasting, g/min 2.33 (1.6, 3.0) 2.82 (2.1, 3.5) 2.65 (2.1, 3.2) 2.82 (2.0, 3.1) .54 .34
Fatclamp, g/min 0.98 (0.2, 1.7)# 1.51 (0.8, 2.2) 2.36 (1.8, 2.9) 2.22 (1.7, 2.7) .47 .27
Proteinfasting, g/min 1.13 (1.1, 1.2) 1.18 (1.1, 1.2) 1.15 (1.1, 1.2) 1.14 (1.1, 1.2) .44 .25
Proteinclamp, g/min 1.02 (1.0, 1.1)# 1.07 (1.0, 1.1) 1.11 (1.1, 1.1) 1.10 (1.1, 1.1) .36 .22
Abbreviation: REE, resting energy expenditure.
Values are means and 95% CIs.
aLog transformation was done to achieve normal distribution.
#P < .05 difference between groups in corresponding time point. P value (training) indicates the mean changes in pre and post measurements in whole
group, P value (training*BAT) indicates whether high BAT and low BAT groups behaved differently for the change in variable with significant difference
between them.
FIGURE 3 Differences between high BAT and low BAT activity groups in insulin-stimulated glucose uptake (GU) (A and B) and fasting FFA
uptake rates (C and D) in muscle and different adipose tissue depots pre- and post-training. Data are means and (95% CI). #P < .0001
differences between the groups at baseline, *P = .02, **P = .0009 mean changes in pre- and post-measurements in whole group (training),
†P = .02, ††P = .01 indicates whether high BAT and low BAT activity groups behaved differently for the change in variable, with significant
difference between them (training*BAT). QF, quadriceps femoris muscle; WAT(A), abdominal subcutaneous WAT; WAT(F), femoral
subcutaneous WAT; VIS, abdominal visceral adipose tissue
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based on 18-FDG uptake values measured using semi-quantitative
standard uptake values. In the present study, instead of standard
uptake values, we used quantitative dynamic PET data and performed
an intervention study for sedentary participants.16 While most BAT
glucose uptake studies in humans use cold exposure, we studied BAT
glucose uptake during hyperinsulinaemia, which has been shown to
be associated with cold-induced BAT glucose uptake.17 Insulin stimu-
lation has been shown to increase BAT glucose uptake 5-fold com-
pared with the fasting state at room temperature in people with
functional BAT.6 Indeed, it can be speculated that the participants
with high BAT have higher BAT insulin sensitivity.
Although the intervention period in the present study was short, it
markedly increased the aerobic capacity and the insulin-stimulated
muscle glucose uptake (muscle insulin sensitivity). As BAT is an insulin-
sensitive tissue, we hypothesized that training would also improve the
BAT insulin sensitivity (BAT glucose uptake during insulin stimulation).
Interestingly, the results showed that training decreased BAT glucose
uptake in the group with higher BAT insulin sensitivity at baseline.
BAT is probably not a source of energy during exercise; thus, the ques-
tion arises of why the human body would reduce BAT substrate uptake
after training. We found no change in whole-body energy consump-
tion and only a tendency towards improved whole-body insulin sensi-
tivity; thus, to maintain whole-body homeostasis, one reason for the
decreased BAT glucose uptake after the exercise training might be that
the body decreases BAT glucose uptake in order to provide substrate
to the increased skeletal muscle glucose uptake;18,19 however, when
we tested skeletal muscle glucose uptake as a covariate, we found that
the change in skeletal muscle glucose uptake did not explain the
decrease in BAT glucose uptake.
In rodents, we have shown that exercise-trained rats have more
glycogen in BAT compared with non-trained animals (Jessen and
Goodyear, unpublished data). Thus, if this is also true in humans, the
increased glycogen levels post-training may inhibit the insulin-
stimulated glucose uptake into BAT, explaining the observed reduc-
tion in BAT glucose uptake after the training in the present study.
In rats, 8 weeks of endurance training decreased BAT mass,
UCP-1 expression, and BAT thermogenic activity.20 Thus, it was sug-
gested that the changes in BAT activity after exercise may be attrib-
utable to a decreased need for BAT heat production since, during
exercise, working muscles produce excess heat.20 In the present
study, we did not find any correlation between BAT glucose uptake
and BAT mass at baseline or a change in BAT mass after 2 weeks of
training intervention.
The radiodensity of BAT is used as a marker of BAT intracellular
triglyceride content.21 Lower BAT radiodensity in overweight people
with type 2 diabetes compared with healthy lean control subjects has
been suggested to indicate a shift towards BAT lipid storage or a lipo-
lytic dysfunction of BAT.22,23 Acute cold exposure increases BAT
radiodensity, indicating a decrease in BAT lipid content.21,24 We did
not find any change in BAT radiodensity, suggesting no exercise-
induced effect on BAT lipid content.
We found that exercise training increased skeletal muscle insulin-
stimulated glucose uptake, but not FFA uptake, which is consistent
with previous data.18,25 Here, we also found that insulin-stimulated
glucose uptake increased in femoral subcutaneous adipose tissue,
and the improvement tended to be higher in the HIIT than in the
MICT group. Previously, moderate- or high-intensity exercise training
has not been found to directly improve insulin-stimulated glucose
uptake in the abdominal or femoral subcutaneous adipose tissue;
however, adipose tissue GLUT4 protein expression has been shown
to increase in people with type 2 diabetes after 4 weeks of bicycle
training26 and previous cross-sectional studies show that endurance
athletes have higher abdominal subcutaneous adipose tissue insulin
sensitivity than untrained subjects.27 It is noteworthy that, in the
present study, the insulin-stimulated glucose uptake increased only in
femoral subcutaneous adipose tissue and not in other fat depots.
Femoral subcutaneous adipose tissue is not involved in muscle con-
traction as such, but is located in close vicinity to the exercising mus-
cles. It is possible, therefore, that exercising skeletal muscles releases
myokines to local adipose tissue depots,19 which may mediate local
adipose tissue glucose uptake.
Interestingly, after stratifying participants based on our previ-
ously defined cut-off criteria for BAT activity, we found that those
with high BAT and those with low BAT had clear differences in base-
line characteristics before the training intervention. The high BAT
group in the present study had lower body adiposity and visceral fat
mass, along with markedly higher insulin sensitivity and HDL choles-
terol concentration, which have all been shown to associate with
BAT glucose uptake.4,28–31 The high BAT group also had higher
whole-body and muscle insulin sensitivity, as well as higher carbohy-
drate and lower fat oxidation during hyperinsulinaemia, indicating
improved metabolic flexibility in changing from fat oxidation during
fasting to carbohydrate oxidation during hyperinsulinaemia. These
data support the concept that high baseline BAT activity may protect
against adiposity and insulin resistance.
The high BAT group also had lower levels of IL-6 and leptin, possi-
bly as a result of lower body adiposity and higher levels of MCP-1. IL-6
and MCP-1 are secreted from macrophages, among other tissues, and
can have both pro- and anti-inflammatory effects. Elevated levels of
these cytokines associate with insulin resistance and are seen in obesity
and type 2 diabetes in humans.32,33 In line with previous studies, the
high BAT activity group had lower levels of leptin compared with the
low BAT activity group in the present study.34 Indeed, the present study
cannot determine whether high BAT activity contributes to a positive
profile of adipokines or the opposite; however, the present study high-
lights that BAT can be a key player in metabolic regulation and a possi-
ble target for pharmacological treatment of insulin resistance.
In rodents, BAT has been shown to secrete IL-6, and exercise-
induced IL-6 activates subcutaneous adipose tissue beiging.35 Stanford
et al.36 have shown that BAT transplantation into the visceral cavity in
mice increased circulating IL-6 levels, which was accompanied by
enhanced energy consumption, reduced adiposity and improved glu-
cose homeostasis in the recipient wild-type but not in IL-6 knockout
mice, indicating that these effects were IL-6-dependent. They
hypothesized that the IL-6-dependent effects may lead to the promo-
tion of lipolysis and increased insulin sensitivity in WAT and the heart
through an increase in GLUT1 protein expression.36 In contrast to our
findings, Vosselman et al.9 did not find a correlation between IL-6 and
cold-induced BAT activity in humans.9 Thus, the role of IL-6 in BAT
metabolism and function in humans warrants further investigation.
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In summary, the present study suggests that humans with active
BAT exhibit a metabolically more favourable phenotype compared
with those without active BAT. BAT appears to behave differently
from skeletal muscle in response to short-term exercise training,
decreasing insulin-stimulated BAT glucose uptake. Thus, exercise
training may downregulate BAT glucose metabolism in humans. The
physiological role for the decreased BAT activation with exercise
training will be important to understand given the attention to
developing novel activators of BAT for increased energy expenditure
and weight loss. The number of participants in the present study was
small, and further investigations are warranted to confirm its findings.
ACKNOWLEDGEMENTS
We thank all the volunteers who participated in this study, the study
nurse Mikko Koivumäki, and the staff of the Turku PET Centre and
Paavo Nurmi Centre for their excellent assistance in the study.
Conflict of interest
None of the authors has any conflict of interest regarding any aspect
of this manuscript.
Author contributions
P. M. contributed to the analysis, results interpretation and writing of
the manuscript. V. S., J. J. E., R. J. M., A. M., J. C. H., K. A. V. and J. K.
contributed to the acquisition of data. K. K. M., J. J. E., E. L., R. J. M.,
M. U. D. contributed to data analysis. P. N., L. J. G., R. J. M., J. J.,
R. P., J. K. and K. K. K. contributed to the study design and critical
revision of the manuscript for important intellectual content. J. C.
H. contributed to the study design, writing and drafting the manu-
script. All authors approved the last version of the manuscript. J. C.
H. is the guarantor of this work and, as such, had access to all study
data and takes responsibility for the integrity of the data and the data
analysis.
REFERENCES
1. Villarroya J, Cereijo R, Villarroya F. An endocrine role for brown adi-
pose tissue? Am J Physiol Endocrinol Metab. 2013;305:E567-E572.
2. Klaus S, Casteilla L, Bouillaud F, Ricquier D. The uncoupling protein
UCP: a membraneous mitochondrial ion carrier exclusively expressed
in brown adipose tissue. Int J Biochem. 1991;23:791-801.
3. Cinti S. The role of brown adipose tissue in human obesity. Nutr
Metab Cardiovasc Dis. 2006;16:569-574.
4. Chondronikola M, Volpi E, Borsheim E, et al. Brown adipose tissue
improves whole-body glucose homeostasis and insulin sensitivity in
humans. Diabetes. 2014;63:4089-4099.
5. Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tis-
sue in healthy adults. N Engl J Med. 2009;360:1518-1525.
6. Orava J, Nuutila P, Lidell ME, et al. Different metabolic responses of
human brown adipose tissue to activation by cold and insulin. Cell
Metab. 2011;14:272-279.
7. Eskelinen JJ, Heinonen I, Loyttyniemi E, et al. Muscle-specific glucose
and free fatty acid uptake after sprint interval and moderate-intensity
training in healthy middle-aged men. J Appl Physiol (1985).
2015;118:1172-1180.
8. Dinas PC, Nikaki A, Jamurtas AZ, et al. Association between habitual
physical activity and brown adipose tissue activity in individuals
undergoing PET-CT scan. Clin Endocrinol (Oxf ). 2015;82:147-154.
9. Vosselman MJ, Hoeks J, Brans B, et al. Low brown adipose tissue
activity in endurance trained compared to lean sedentary men. Int J
Obes (Lond). 2015;39:1696-1702.
10. Kiviniemi AM, Tulppo MP, Eskelinen JJ, et al. Cardiac autonomic
function and high-intensity interval training in middle-age men. Med
Sci Sports Exerc. 2014;46:1960-1967.
11. Merilainen PT. Metabolic monitor. Int J Clin Monit Comput.
1987;4:167-177.
12. Harris JA, Benedict FG. A biometric study of human basal metabo-
lism. Proc Natl Acad Sci U S A. 1918;4:370-373.
13. Ouellet V, Routhier-Labadie A, Bellemare W, et al. Outdoor tempera-
ture, age, sex, body mass index, and diabetic status determine the
prevalence, mass, and glucose-uptake activity of 18 F-FDG-detected
BAT in humans. J Clin Endocrinol Metab. 2011;96:192-199.
14. Muzik O, Mangner TJ, Leonard WR, Kumar A, Janisse J,
Granneman JG. 15O PET measurement of blood flow and oxygen
consumption in cold-activated human brown fat. J Nucl Med.
2013;54:523-531.
15. Abate N, Burns D, Peshock RM, Garg A, Grundy SM. Estimation of adi-
pose tissue mass by magnetic resonance imaging: validation against
dissection in human cadavers. J Lipid Res. 1994;35:1490-1496.
16. Muzi M, O’Sullivan F, Mankoff DA, et al. Quantitative assessment of
dynamic PET imaging data in cancer imaging. Magn Reson Imaging.
2012;30:1203-1215.
17. Orava J, Nuutila P, Noponen T, et al. Blunted metabolic responses to
cold and insulin stimulation in brown adipose tissue of obese humans.
Obesity (Silver Spring). 2013;21:2279-2287.
18. Reichkendler MH, Auerbach P, Rosenkilde M, et al. Exercise training
favors increased insulin-stimulated glucose uptake in skeletal muscle
in contrast to adipose tissue: a randomized study using FDG PET ima-
ging. Am J Physiol Endocrinol Metab. 2013;305:E496-E506.
19. Pedersen BK, Akerstrom TC, Nielsen AR, Fischer CP. Role of myo-
kines in exercise and metabolism. J Appl Physiol (1985).
2007;103:1093-1098.
20. Wu MV, Bikopoulos G, Hung S, Ceddia RB. Thermogenic capacity is
antagonistically regulated in classical brown and white subcutaneous
fat depots by high fat diet and endurance training in rats: impact on
whole-body energy expenditure. J Biol Chem. 2014;289:34129-
34140.
21. Ouellet V, Labbe SM, Blondin DP, et al. Brown adipose tissue oxida-
tive metabolism contributes to energy expenditure during acute cold
exposure in humans. J Clin Invest. 2012;122:545-552.
22. Blondin DP, Labbe SM, Noll C, et al. Selective impairment of glucose
but not fatty acid or oxidative metabolism in brown adipose tissue of
subjects with type 2 diabetes. Diabetes. 2015;64:2388-2397.
23. Pasarica M, Sereda OR, Redman LM, et al. Reduced adipose tissue
oxygenation in human obesity: evidence for rarefaction, macrophage
chemotaxis, and inflammation without an angiogenic response. Diabe-
tes. 2009;58:718-725.
24. Baba S, Jacene HA, Engles JM, Honda H, Wahl RL. CT Hounsfield
units of brown adipose tissue increase with activation: preclinical and
clinical studies. J Nucl Med. 2010;51:246-250.
25. Hannukainen JC, Nuutila P, Kaprio J, et al. Relationship between local
perfusion and FFA uptake in human skeletal muscle-no effect of
increased physical activity and aerobic fitness. J Appl Physiol (1985).
2006;101:1303-1311.
26. Hussey SE, McGee SL, Garnham A, Wentworth JM, Jeukendrup AE,
Hargreaves M. Exercise training increases adipose tissue GLUT4
expression in patients with type 2 diabetes. Diabetes Obes Metab.
2011;13:959-962.
27. Stallknecht B, Larsen JJ, Mikines KJ, Simonsen L, Bulow J, Galbo H.
Effect of training on insulin sensitivity of glucose uptake and lipolysis
in human adipose tissue. Am J Physiol Endocrinol Metab. 2000;279:
E376-E385.
28. Saito M, Okamatsu-Ogura Y, Matsushita M, et al. High incidence of
metabolically active brown adipose tissue in healthy adult humans:
effects of cold exposure and adiposity. Diabetes. 2009;58:1526-
1531.
29. Matsushita M, Yoneshiro T, Aita S, Kameya T, Sugie H, Saito M.
Impact of brown adipose tissue on body fatness and glucose metabo-
lism in healthy humans. Int J Obes (Lond). 2014;38:812-817.
MOTIANI ET AL. 1387
30. Wang Q, Zhang M, Xu M, et al. Brown adipose tissue activation is
inversely related to central obesity and metabolic parameters in adult
human. PLoS ONE. 2015;10:e0123795.
31. Cypess AM, Lehman S, Williams G, et al. Identification and impor-
tance of brown adipose tissue in adult humans. N Engl J Med.
2009;360:1509-1517.
32. Dela F, Stallknecht B. Effect of physical training on insulin secretion
and action in skeletal muscle and adipose tissue of first-degree rela-
tives of type 2 diabetic patients. Am J Physiol Endocrinol Metab.
2010;299:E80-E91.
33. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in
adipose tissue. J Clin Invest. 2003;112:1785-1788.
34. Zhang Q, Ye H, Miao Q, et al. Differences in the metabolic status of
healthy adults with and without active brown adipose tissue. Wien
Klin Wochenschr. 2013;125:687-695.
35. Knudsen JG, Murholm M, Carey AL, et al. Role of IL-6 in exercise
training- and cold-induced UCP1 expression in subcutaneous white
adipose tissue. PLoS ONE. 2014;9:e84910.
36. Stanford KI, Middelbeek RJ, Townsend KL, et al. Brown adipose tis-
sue regulates glucose homeostasis and insulin sensitivity. J Clin Invest.
2013;123:215-223.
SUPPORTING INFORMATION
Additional Supporting Information may be found online in the sup-
porting information tab for this article.
How to cite this article: Motiani P, Virtanen KA, Motiani KK,
et al. Decreased insulin-stimulated brown adipose tissue glu-
cose uptake after short-term exercise training in healthy
middle-aged men. Diabetes Obes Metab. 2017;19:1379–1388.
https://doi.org/10.1111/dom.12947
1388 MOTIANI ET AL.
